SCHEMBL28129477

SCHEMBL28129477

Cc1cncc(C(=O)NC(C)c2ccc(OCC(F)(F)F)nc2)n1

nearest known ligand 0.42

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 3/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
CYP2J2 P51589 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
PDE2A O00408 11/20 0.41
IDH1 O75874 1/20 0.41
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
GRM5 P41594 1/20 0.38
CACNA1G O43497 1/20 0.38
CACNA1H O95180 1/20 0.38
CNR2 P34972 1/20 0.38
KCNH2 Q12809 1/20 0.38
CACNA1I Q9P0X4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tert-Butylamine SCHEMBL28093808 0.96 EPHX2 (0.42) EPHX2CYP2C9CYP2C19CYP2J2L3MBTL1
SCHEMBL28840721 0.85 HTT (0.56) EPHX2CYP2C9CYP2C19CYP2J2L3MBTL1
Tert-Butylamine SCHEMBL28129319 0.84 PDE2A (0.43) PDE2AHTTSMN1; SMN2CACNA1GCACNA1H
SCHEMBL28806898 0.83 PDE2A (0.43) EPHX2CYP2C9CYP2C19CYP2J2L3MBTL1
SCHEMBL2716544 0.83 PDE2A (0.43) EPHX2CYP2C9CYP2C19CYP2J2PDE2A
Tert-Butylamine SCHEMBL28129278 0.82 EPHX2 (0.40) EPHX2CYP2C9PDE2AGRM5CNR2
SCHEMBL2713970 0.82 GRN (0.49) EPHX2CYP2C9CYP2C19CYP2J2L3MBTL1
SCHEMBL27931828 0.82 EPHX2 (0.43) EPHX2CYP2C9CYP2C19CYP2J2L3MBTL1
SCHEMBL2719084 0.82 L3MBTL1 (0.55) EPHX2CYP2C9CYP2C19CYP2J2L3MBTL1
Tert-Butylamine SCHEMBL28093771 0.82 HTT (0.53) EPHX2CYP2C9CYP2C19CYP2J2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106478497-A Aryl amine derivatives as TTX S blocker 拉夸里亚创药株式会社 2017-03-08 CN disclosed